Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00113789
Status:
COMPLETED
Last Update Posted:
2009-02-13
First Post:
2005-06-10
Brief Title:
Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer
Sponsor:
Amgen
Organization:
Amgen
Organization Data
Organization:
Amgen
Class:
INDUSTRY
Study ID:
20030122
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amgen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Global Development Leader
Old Organization:
Amgen Inc